Pentoxifylline impedes migration in B16F10 melanoma by modulating Rho GTPase activity and actin organisation

European Journal of Cancer

Volumn 44, Issue 11, 2008, Pages 1587-1595

  Dua, Pooja ^a   Gude, Rajiv P ^a  

^a CANCER RESEARCH INSTITUTE   (India)

Author keywords

Actin organisation; B16F10 melanoma; Migration; Pentoxifylline; Protein Kinase A; Rho GTPase

Indexed keywords

ACTIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; PENTOXIFYLLINE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; LAMELLIPODIUM; MELANOMA; NONHUMAN; PRIORITY JOURNAL; STRESS FIBER;

ACTINS; ANIMALS; CELL MOVEMENT; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME INHIBITORS; GTPASE-ACTIVATING PROTEINS; MELANOMA; PENTOXIFYLLINE; SKIN NEOPLASMS;

EID: 46049105906     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.04.009     Document Type: Article

References (36)

1. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 1 (2000) 57-70
2. Ridley A.J., Allen W.E., Peppelenbosch M., et al. Rho family proteins and cell migration. Biochem Soc Symp 65 (1999) 111-123
3. Nobes C.D., and Hall A. Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem Soc Trans 23 3 (1995) 456-459
4. Ridley A.J. Rho family proteins: coordinating cell responses. Trends Cell Biol 11 12 (2001) 471-477
5. Bokoch G.M., Bohl B.P., and Chuang T.H. Guanine nucleotide exchange regulates membrane translocation of Rac/Rho GTP-binding proteins. J Biol Chem 269 50 (1994) 31674-31679
6. Ellerbroek S.M., Wennerberg K., and Burridge K. Serine phosphorylation negatively regulates RhoA in vivo. J Biol Chem 278 21 (2003) 19023-19031
7. Sastry S.K., Lyons P.D., Schaller M.D., et al. PTP-PEST controls motility through regulation of Rac1. J Cell Sci 115 Pt 22 (2002) 4305-4316
8. Garton A.J., and Tonks N.K. PTP-PEST: a protein tyrosine phosphatase regulated by serine phosphorylation. Embo J 13 16 (1994) 3763-3771
9. Qian Y., Zhong X., Flynn D.C., et al. ILK mediates actin filament rearrangements and cell migration and invasion through PI3K/Akt/Rac1 signaling. Oncogene 24 19 (2005) 3154-3165
10. Hammerschmidt D.E., Kotasek D., McCarthy T., et al. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor. J Lab Clin Med 112 2 (1988) 254-263
11. Gordon S., Witul M., Cohen H., et al. Studies on platelet aggregation inhibitors in vivo. VIII. Effect of pentoxifylline on spontaneous tumor metastasis. J Med 10 6 (1979) 435-443
12. Gude R.P., Ingle A.D., and Rao S.G. Inhibition of lung homing of B16F10 by pentoxifylline, a microfilament depolymerizing agent. Cancer Lett 106 2 (1996) 171-176
13. Gude R.P., Binda M.M., Boquete A.L., et al. Inhibition of endothelial cell proliferation and tumor-induced angiogenesis by pentoxifylline. J Cancer Res Clin Oncol 127 10 (2001) 625-630
14. Dua P., and Gude R.P. Antiproliferative and antiproteolytic activity of pentoxifylline in cultures of B16F10 melanoma cells. Cancer Chemother Pharmacol 58 2 (2006) 195-202
15. Dua P., Ingle A., and Gude R.P. Suramin augments the antitumor and antimetastatic activity of pentoxifylline in B16F10 melanoma. Int J Cancer 121 7 (2007) 1600-1608
16. Ratheesh A., Ingle A., and Gude R.P. Pentoxifylline modulates cell surface integrin expression and integrin mediated adhesion of B16F10 cells to extracellular matrix components. Cancer Biol Ther 6 11 (2007)
17. Murata J., Saiki I., Yoneda J., et al. Differences in chemotaxis to fibronectin in weakly and highly metastatic tumor cells. Jpn J Cancer Res 83 12 (1992) 1327-1333
18. Zhao W., Liu H., Xu S., et al. Migration and metalloproteinases determine the invasive potential of mouse melanoma cells, but not melanin and telomerase. Cancer Lett 162 Suppl (2001) S49-S55
19. Gude R.P., Binda M.M., Presas H.L., et al. Studies on the mechanisms responsible for inhibition of experimental metastasis of B16-F10 murine melanoma by pentoxifylline. J Biomed Sci 6 2 (1999) 133-141
20. Shen M.R., Chiang P.H., Yang R.C., et al. Pentoxifylline stimulates human sperm motility both in vitro and after oral therapy. Br J Clin Pharmacol 31 6 (1991) 711-714
21. Elferink J.G., Huizinga T.W., and de Koster B.M. The effect of pentoxifylline on human neutrophil migration: a possible role for cyclic nucleotides. Biochem Pharmacol 54 4 (1997) 475-480
22. Dominguez-Jimenez C., Sancho D., Nieto M., et al. Effect of pentoxifylline on polarization and migration of human leukocytes. J Leukoc Biol 71 4 (2002) 588-596
23. Murata K., Kameyama M., Fukui F., et al. Phosphodiesterase type III inhibitor, cilostazol, inhibits colon cancer cell motility. Clin Exp Metastasis 17 6 (1999) 525-530
24. Morton D.M., and Tchao R. Regulation of motility and cytoskeletal organization of rat bladder carcinoma cells by cyclic AMP. Cell Motil Cytoskeleton 29 4 (1994) 375-382
25. Kim N.Y., Pae H.O., Kim Y.C., et al. Pentoxifylline potentiates nitric oxide production in interleukin-1beta-stimulated vascular smooth muscle cells through cyclic AMP-dependent protein kinase A pathway. Gen Pharmacol 35 4 (2000) 205-211
26. Rawadi G., Ferrer C., Spinella-Jaegle S., et al. 1-(5-oxohexyl)-3,7-Dimethylxanthine, a phosphodiesterase inhibitor, activates MAPK cascades and promotes osteoblast differentiation by a mechanism independent of PKA activation (pentoxifylline promotes osteoblast differentiation). Endocrinology 142 11 (2001) 4673-4682
27. Itoh T., and Furuichi Y. Hot-water extracts from adzuki beans (Vigna angularis) stimulate not only melanogenesis in cultured mouse B16 melanoma cells but also pigmentation of hair color in C3H mice. Biosci Biotechnol Biochem 69 5 (2005) 873-882
28. No J.K., Kim Y.J., Lee J.S., et al. Inhibition of melanogenic activity by 4,4'-dihydroxybiphenyl in melanoma cells. Biol Pharm Bull 29 1 (2006) 14-16
29. Sullivan R.M., Stone M., Marshall J.F., et al. Photo-induced inactivation of protein kinase calpha by dequalinium inhibits motility of murine melanoma cells. Mol Pharmacol 58 4 (2000) 729-737
30. Sanz-Navares E., Fernandez N., Kazanietz M.G., et al. Atypical protein kinase Czeta suppresses migration of mouse melanoma cells. Cell Growth Differ 12 10 (2001) 517-524
31. Arikawa K., Takuwa N., Yamaguchi H., et al. Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity. J Biol Chem 278 35 (2003) 32841-32851
32. Yamamura S., Hakomori S., Wada A., et al. Sphingosine-1-phosphate inhibits haptotactic motility by overproduction of focal adhesion sites in B16 melanoma cells through EDG-induced activation of Rho. Ann N Y Acad Sci 905 (2000) 301-307
33. Heo J.C., Park J.Y., Woo S.U., et al. Dykellic acid inhibits cell migration and tube formation by RhoA-GTP expression. Biol Pharm Bull 29 11 (2006) 2256-2259
34. Ridley A.J., and Hall A. Signal transduction pathways regulating Rho-mediated stress fibre formation: requirement for a tyrosine kinase. Embo J 13 11 (1994) 2600-2610
35. Rao K.M., Crawford J., Currie M.S., et al. Actin depolymerization and inhibition of capping induced by pentoxifylline in human lymphocytes and neutrophils. J Cell Physiol 137 3 (1988) 577-582
36. Ohta Y., Akiyama T., Nishida E., et al. Protein kinase C and cAMP-dependent protein kinase induce opposite effects on actin polymerizability. FEBS Lett 222 2 (1987) 305-310